Form 4: United Therapeutics Director Dwek Exercises Options and Sells Shares
SEC Form 4 Filing
Director Raymond Dwek exercised stock options and sold shares of United Therapeutics Corp (UTHR) on August 2, 2024.
Summary
- On August 2, 2024, Raymond Dwek, a director of United Therapeutics Corp (UTHR), exercised stock options for 5,000 shares at a price of $175.43 per share.
- Following the exercise of options, Dwek sold a total of 5,000 shares in multiple transactions.
- The sales occurred at weighted average prices ranging from $320.3883 to $330.39 per share.
- After these transactions, Dwek directly owns 1,750 shares of United Therapeutics Corp.
- Dwek also holds 10,000 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. These filings are monitored by investors to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a director.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date stock options were granted. |
| 08/02/2024 | Date of option exercise and share sales. |
| 06/26/2025 | Expiration date of stock options. |
| 08/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.